SCHEMBL4452322

SCHEMBL4452322

[O]C(=O)c1ccc(Cl)c(Cl)c1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.44
CYP3A4 P08684 1/20 0.44
TSHR P16473 3/20 0.41
CASP1 P29466 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ALDH1A1 P00352 4/20 0.38
KMT2A Q03164 1/20 0.38
ATM Q13315 1/20 0.38
HIF1A Q16665 1/20 0.38
GPR27 Q9NS67 1/20 0.37
SRD5A2 P31213 1/20 0.37
TP53 P04637 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
MAPT P10636 2/20 0.36
KDM4E B2RXH2 1/20 0.36
CES2 O00748 1/20 0.36
CES1 P23141 1/20 0.36
CSNK2A2 P19784 1/20 0.35
CSNK2B P67870 1/20 0.35
CSNK2A1 P68400 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL432644 0.80 TSHR (0.64) MAPK1CYP3A4TSHRCASP1SMN1; SMN2
SCHEMBL29886586 0.80 TSHR (0.64) MAPK1CYP3A4TSHRCASP1SMN1; SMN2
SCHEMBL967909 0.80 CYP3A4 (0.44) MAPK1CYP3A4TSHRCASP1SMN1; SMN2
SCHEMBL9586215 0.79 SLC6A4 (0.39) MAPK1CYP3A4TSHRCASP1SMN1; SMN2
SCHEMBL3121452 0.78 KMT2A (0.55) MAPK1CYP3A4TSHRALDH1A1KMT2A
SCHEMBL1679916 0.78 CYP3A4 (0.42) MAPK1CYP3A4TSHRCASP1SMN1; SMN2
SCHEMBL30610932 0.78 CYP3A4 (0.42) MAPK1CYP3A4TSHRCASP1SMN1; SMN2
SCHEMBL8617010 0.78 TSHR (0.61) MAPK1CYP3A4TSHRCASP1SMN1; SMN2
SCHEMBL2831621 0.78 TSHR (0.68) TSHRALDH1A1KMT2AKDM4ECES2
SCHEMBL10606007 0.78 TSHR (0.61) MAPK1CYP3A4TSHRCASP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7629494-B2 Process for producing cyclopropylphenol derivative MITSUI CHEMICALS AGRO, INC. (JP) 2009-12-08 US disclosed
US-20090054681-A1 Production Process of cyclopropylphenol derivatives SANKYO AGRO COMPANY, LIMITED (JP) 2009-02-26 US disclosed
EP-1880987-A1 PROCESS FOR PRODUCING CYCLOPROPYLPHENOL DERIVATIVE Sankyo Agro Company, Limited (JP) 2008-01-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054681-A1 Production Process of cyclopropylphenol derivatives CBR3, CYP4X1, CYP4A11 MAPK1 2748/4885CYP3A4 8/4885TSHR 249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.